News
Agilent Technologies and Oxford Gene Technology Expand Microarray and Sequencing Partnership
Agilent Technologies Inc. and Oxford Gene Technology today announced they have expanded an existing partnership into an exclusive agreement for Agilent to provide OGT with oligonucleotide microarrays and SureSelect target enrichment products for next-generation sequencing. ...
News
Ranbaxy Honored With Nabia Award For Excellence in New Jersey Business Expansion
Ranbaxy Inc., a research-based pharmaceutical company that manufactures generic product formulations, OTC and branded drug products, has been honored with the New Jersey Business Industry Association’s (NJBIA) Award for Excellence in Business Expansion and Economic Contribution to the...
News
AstraZeneca sticks to R&D partnership track in China
As global pharmas race to grab a piece of the growing Chinese drug market, London-based drug giant AstraZeneca appears to be sticking to an R&D strategy that emphasizes partnerships with local stakeholders over buyouts to gain traction in...
News
Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
Sanofi Pasteur, the vaccines division of Sanofi is donating to the World Health Organization a vaccine strain used for polio eradication. The biological material given by Sanofi Pasteur is the original viral seed used to produce large quantities...
News
CMC Biologics, Inspiration team up to manufacture hemophilia B drug
Denmark based CMC Biologics and US based Inspiration Biopharmaceuticals have signed a supply agreement to manufacturing bulk IB1001 as a treatment and preventive measure of bleeding in individuals with hemophilia B. The agreement allows...
News
Nuevolution signs agreement with Boehringer
Nuevolution has signed an agreement with Boehringer Ingelheim to screen a range of small molecules for discovering and enhancing drug candidates by using Nuevolution's proprietary Chemetics drug discovery technology. The drugs which will be...
News
Moberg licenses OTC Nalox drug to Meda
Moberg Derma has given marketing license for its over-the-counter Nalox to Meda as a treatment for discolored and damaged nails caused by nail fungus or nail psoriasis. The new deal covers several major European...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















